title: Low-grade oligodendroglioma: current treatments and future hopes.
abstract: Current treatment modalities for low-grade gliomas include surgery, radiotherapy and chemotherapy. Management of these ultimately incurable tumors remains controversial, particularly the timing and extent of surgery, and the optimal sequence of radiotherapy and chemotherapy thereafter. Two ongoing Phase III trials should provide definitive answers to some of these controversial issues in the treatment of low-grade gliomas and confirm the impact of molecular predictors of response and outcome. This review will discuss recent progress and topical issues in the treatment of low-grade gliomas.
authors.affiliation: Room 7-702, Princess Margaret Hospital, Toronto, Canada. zarnie.lwin@uhn.on.ca
authors.forename: Zarnie
authors.initials: Z
authors.lastname: Lwin
authors.forename: Hui K
authors.initials: HK
authors.lastname: Gan
authors.forename: Warren P
authors.initials: WP
authors.lastname: Mason
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D001254:Astrocytoma / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D001932:Brain Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D003131:Combined Modality Therapy; D006801:Humans; D009837:Oligodendroglioma / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant
chemical_list: D018906:Antineoplastic Agents, Alkylating